Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOB015B in mild to moderate distal subungual onychomycosis
NCT02859519Phase 3Completed
- Sponsor
- Moberg Pharma AB
- Start
- Oct 2016
- Primary completion
- Nov 2019
- Modality
- Transdermal Patches, Orthosteric Ligands, Hydrogel Systems
- Countries
- 2
01
Overview
A Phase 3 trial of Terclara in distal subungual onychomycosis (DSO), sponsored by Moberg Pharma AB. Started Oct 2016; status: completed.
02
Drugs
Terclara
03
Conditions
distal subungual onychomycosis (DSO)
Beyond the preview
Go deeper on NCT02859519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02859519.